In planta protein sialylation through overexpression of the respective mammalian pathway.
about
Biomanufacturing of protective antibodies and other therapeutics in edible plant tissues for oral applicationsPlant-based solutions for veterinary immunotherapeutics and prophylacticsImmune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesAdvanced engineering of lipid metabolism in Nicotiana benthamiana using a draft genome and the V2 viral silencing-suppressor proteinGoldenBraid: an iterative cloning system for standardized assembly of reusable genetic modulesRapid high yield production of different glycoforms of Ebola virus monoclonal antibodyEnhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant.Molecular farming on rescue of pharma industry for next generations.Engineering of complex protein sialylation in plants.Expression and glycoengineering of functionally active heteromultimeric IgM in plants.Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders.Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana.Designed IgM from glycoengineering.Production of complex multiantennary N-glycans in Nicotiana benthamiana plants.Biological significance of complex N-glycans in plants and their impact on plant physiologyProtein N-glycosylation in eukaryotic microalgae and its impact on the production of nuclear expressed biopharmaceuticals.Protein production from the structural genomics perspective: achievements and future needs.Plant glyco-biotechnology on the way to synthetic biologyGeneration of biologically active multi-sialylated recombinant human EPOFc in plants.Oligomerization status influences subcellular deposition and glycosylation of recombinant butyrylcholinesterase in Nicotiana benthamiana.Emerging antibody products and Nicotiana manufacturing.Characterization of plants expressing the human β1,4-galactosyltrasferase geneEmerging technologies for making glycan-defined glycoproteinsA new glycoengineered insect cell line with an inducibly mammalianized protein N-glycosylation pathway.Limited Addition of the 6-Arm β1,2-linked N-Acetylglucosamine (GlcNAc) Residue Facilitates the Formation of the Largest N-Glycan in PlantsGlycan modulation and sulfoengineering of anti-HIV-1 monoclonal antibody PG9 in plants.Processing of complex N-glycans in IgG Fc-region is affected by core fucosylationInnovative use of a bacterial enzyme involved in sialic acid degradation to initiate sialic acid biosynthesis in glycoengineered insect cells.Plant-derived virus-like particles as vaccinesGlycoengineering of plants yields glycoproteins with polysialylation and other defined N-glycoforms.Expression of human butyrylcholinesterase with an engineered glycosylation profile resembling the plasma-derived orthologueMolecular farming: production of drugs and vaccines in higher plants.Plant glycans: friend or foe in vaccine development?Chloroplasts as expression platforms for plant-produced vaccines.Glycoprotein production in moss bioreactors.The use of plants for the production of therapeutic human peptides.Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation.IgG-Fc glycoengineering in non-mammalian expression hostsGlyco-engineering in plants to produce human-like N-glycan structures.Challenges in O-glycan engineering of plants.
P2860
Q26766215-1A3EE778-D330-494B-8258-D8A99621A1A3Q27000876-1186AF42-EF90-4BD5-9C09-D5CECE6E4B9FQ28069362-79C750E3-4B53-4D8A-A1D6-A118DE1D0D95Q28484569-A565E708-9542-4385-86E8-46E02C91593AQ28742820-FDA4AAC4-83F5-4956-B424-B7507E3E67A0Q28743509-20A6C4ED-6B91-44E5-9BCB-4A7D7427741DQ30224854-E638AF92-86AC-4362-928E-C83BBAA712F5Q30252148-120390DE-B2DB-4D85-B6AE-BAFEF6382A1BQ30313981-3F50373B-1A27-4FAB-80B4-5E3A18B6CA77Q30412932-5DE8E8F4-1C5F-4B95-9394-56345CF15846Q33437488-B8831836-84A9-4D2B-B688-D310CE3FD1EFQ33619065-CDACB252-B6C8-4CA5-9F4B-D7E825E65C6BQ33674739-E9A7ED4F-B50D-45B9-9CB4-ADB73D24126FQ33793024-30830BD9-BCB7-4A5C-9D73-691FEB3CC5A4Q33928774-33DEDAB1-52B1-4027-AEE9-889ADF0184ADQ34054932-F3F22BF0-9CDE-4651-AF78-4932964099C1Q34174863-D8F14C02-5AFD-4EB7-BD68-7D6853F13C38Q34304795-0F6AFB1D-1C27-4676-8C7C-3751C0AB14E0Q34571378-70BCE7DB-AE10-4CAF-AAF5-850306C00E21Q34693466-BFAEC6B2-08B8-439E-9054-910668D68DEAQ35194874-5D5D2160-CE00-49F1-8C81-1D23BFD0DE6FQ35611104-9B084838-F877-4A18-8798-9A39DD29DBB7Q35685635-BDDD9899-11D7-42B3-B228-C98D3B3EFB7EQ35703121-3DF74006-81B3-4904-A3C6-4980CC6E0BC8Q35860484-57DCB62D-EB87-43B1-9EAC-7002491882A6Q36179265-F6D70D33-198F-4F0E-A319-DDA37545A28BQ36211489-4E489CAB-190E-46E8-AC16-F0544B6EB652Q36392872-31A76E3B-C415-464D-A540-33DED18032B2Q36888029-A963C0CB-63E6-4401-B718-4FD23B4313F4Q37213813-1CADFC2B-BE3A-4064-8CAB-EA754CD7AD9DQ37684636-4F478038-5864-45C5-92E2-E175F02757E9Q37768654-A7D59E1B-4372-42A9-863B-321D7A0C025EQ37776714-E7C20E44-C56F-4D6C-90A1-F9C763C8382EQ37776719-27255139-6929-4A47-8A98-9E68D7D0A045Q37940883-BF1D7965-08B9-4582-9ED7-B64BA8138C68Q37973256-CBFEAE18-778F-4F2D-8276-EA0D6B67F561Q38012151-1F5CCB24-0805-49F8-A491-8850D2D57473Q38013479-2F734A7D-7E40-4528-BADF-4C2916A1C879Q38034471-C1C02294-59E9-4229-85E0-7910CC82A188Q38046835-C156D37C-ADA7-4F32-8113-AEFD82F8E94E
P2860
In planta protein sialylation through overexpression of the respective mammalian pathway.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
In planta protein sialylation through overexpression of the respective mammalian pathway.
@en
type
label
In planta protein sialylation through overexpression of the respective mammalian pathway.
@en
prefLabel
In planta protein sialylation through overexpression of the respective mammalian pathway.
@en
P2093
P2860
P50
P356
P1476
In planta protein sialylation through overexpression of the respective mammalian pathway.
@en
P2093
Alexandra Castilho
Heribert Quendler
Johannes Stadlmann
Josephine Grass
Renaud Leonard
P2860
P304
15923-15930
P356
10.1074/JBC.M109.088401
P407
P577
2010-03-20T00:00:00Z